期刊文献+

重叠综合征患者炎性因子与细胞免疫的关系 被引量:4

Relationship of inflammatory factors with cellular immunity in the patients with the overlap syndrome
原文传递
导出
摘要 目的探讨重叠综合征患者血清肿瘤坏死因子(tumor necrosis factor,TNF)-α、白细胞介素(interleukin,IL)-6、C反应蛋白(C-reactive protein,CRP)和细胞免疫水平及二者间关系。方法阻塞性睡眠呼吸暂停低通气综合征患者25例(OSAS组)、慢性阻塞性肺疾病患者25例(COPD组)、重叠综合征患者25例(OS组)和对照组25例,4组采用ELISA法检测血清TNF-α、IL-6、CRP水平,采用流式细胞仪检测T淋巴细胞亚群水平。结果 OS组血清TNF-α、IL-6、CRP水平高于对照组、OSAS组和COPD组(P<0.01),CD4+/CD8+低于对照组、COPD组与OSAS组(P<0.01);OS组炎性因子TNF-α、IL-6、CRP与CD4+/CD8+呈明显负相关(r=-0.754,P=0.013;r=-0.503,P=0.027;r=-0.552,P=0.008)。结论重叠综合征患者存在全身性系统性炎症反应,可引起细胞免疫功能紊乱。 Objective To explore the relationship of the levels of inflammation factor tumor necrosis factor a (TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP) with cellular immune in the overlap syndrome patients. Methods The levels of serum TNF-α, IL- 6 and CRP were detected by using ELISA technique, and the T-lymphocyte subsets were determined by using flowcytometry method in 25 cases of obstructive sleep apnea syndrome (OSAS group), 25 cases of chronic obstructive pulmonary disease (COPD group), 25 cases of overlap syndrome (OS group) and 25 cases of normal control (control group). Results The levels of IL-6, CRP and TNF-α were higher, and the CD4+/CD8+ ratios were lower in OS group than those in the other three groups (P〈0.01). The levels of TNF-α, IL-6 and CRP were negatively correlated with CD4+/CD8+ ratio (r= 0.754, P=0. 013; r=-0. 503, P 0.027; r=-0. 552, P=0. 008). Conclusion The systemic inflammation reaction exists in the overlap syndrome patients, which causes immunity disorders.
作者 张军营 凌敏
出处 《中华实用诊断与治疗杂志》 2013年第10期973-975,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 慢性阻塞性肺疾病 阻塞性睡眠呼吸暂停低通气综合征 重叠综合征 炎症因子 细胞免疫 Chronic obstructive pulmonary disease obstructive sleep apnea hypopnea syndrome overlap syndrome inflammation factor cellular immunity
  • 相关文献

参考文献11

二级参考文献73

  • 1杨海波,王英,董明敏.老年阻塞性睡眠呼吸暂停综合征患者血浆超敏C反应蛋白浓度的研究[J].中国老年学杂志,2004,24(12):1126-1127. 被引量:2
  • 2沈玉光,许金良,杨宗林,赵婷茹.流式细胞术测肺癌患者外周血T细胞亚群及其与临床病理的关系[J].实用诊断与治疗杂志,2006,20(2):101-102. 被引量:22
  • 3Orth M, Rasche K, Bauer IT, et, al. Incidence d chronic obstructive respiratory tract disease in patients with obstructive sleep apnea[J]. Pneumologic,1996,50(4) :286 - 289.
  • 4Conte G, Rigon N, Peerron A, et al. Acute Cardiovascular disease and respiratory sleep disorders[J]. Minerva Cardioangiol, 1999,47(6) : 195 - 202.
  • 5Soto Campos Ja, Cano Gomez S, Fernandez Guerra J,et,al Hypercapnic stimulation response in the syndrome of sleep obstructive apnea.Comparison of reinhalation and steady state[J]. Arch- Bronconeumol, 1996,32(7):341 -347.
  • 6Singh J, Suruchi A. Anti TNF-α strategy: Present status of this therapeutic paradigm[J]. Indian J Pharmacol, 2004, 36, (1): 10-14.
  • 7Keystone EC. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis[J]. Rheum Dis Clin North Am, 2001, 27: 427-443.
  • 8Feldmann M, Maini RN. Anti-TNF-αlpha therapy of rheumatoid arthritis: What we have learnt?[J]. Ann Rev Immunol, 2001, 19: 163-196.
  • 9Francesca B P, Claudia A, Roberto C, et al. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment[J]. Arthritis Res Ther, 2004, 6: R264-272.
  • 10Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease[J]. N Engl J Med, 1999, 340: 1398-1405.

共引文献46

同被引文献29

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部